← Open Payments lookup

CHELSEY WINNINGHAM: Open Payments

NPI 1083481139 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$458 in 26 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $49 · 2025 $458

Food & beverage: $458
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$93
Novo Nordisk Inc4$71
ABBVIE INC.4$67
Amgen Inc.3$59
GlaxoSmithKline, LLC.2$35
Madrigal Pharmaceuticals1$23
Lilly USA, LLC1$19
ABIOMED1$17
PFIZER INC.1$17
SANOFI-AVENTIS U.S. LLC1$15

Products named: AIRSUPRA, Rybelsus, UBRELVY, OTEZLA, TRELEGY ELLIPTA, JARDIANCE, REZDIFFRA, REPATHA.

Industry payments across TX — which companies pay providers there.